|
Group
|
n
|
Median
|
Mean
|
S.D.
|
Lower-upper quartile
|
p-value
|
|---|
|
CEA (ng/ml)
|
|
healthy controls
|
58
|
1.13
|
1.62
|
1.46
|
0.84 – 1.75
|
0.04
|
|
cancer patients
|
37
|
1.54
|
2.45
|
3.11
|
1.00 – 2.11
| |
|
CA15-3 (U/ml)
|
|
healthy controls
|
58
|
12.3
|
13.28
|
5.45
|
9.5 – 16.4
|
0.63
|
|
cancer patients
|
37
|
14.0
|
13.74
|
5.79
|
8.3 – 18.5
| |
|
CYFRA 21.1 (ng/ml)
|
|
healthy controls
|
58
|
0.41
|
0.53
|
0.48
|
0.24 – 0.60
|
0.06
|
|
cancer patients
|
37
|
0.54
|
0.63
|
0.44
|
0.35 – 0.75
| |
|
Leptin (ng/ml)
|
|
healthy controls
|
58
|
27.70
|
33.51
|
23.01
|
17.80 – 41.80
|
0.05
|
|
cancer patients
|
37
|
23.01
|
24.19
|
16.09
|
10.02 – 31.11
| |
|
Osteopontin (ng/ml)
|
|
healthy controls
|
50
|
45.90
|
47.13
|
11.9
|
38.70 – 52.20
|
0.0003
|
|
cancer patients
|
73
|
54.73
|
59.47
|
15.37
|
47.13 – 66.98
| |
- Shown are median, mean and S.D. values, as well as lower and upper quartiles. The p-values are for differences between patients and healthy controls measured by the Kruskal-Wallis test.
